Prosecution Insights
Last updated: November 20, 2026

Madeline E Braun, USPTO Patent Examiner

Listed by the USPTO as BRAUN, MADELINE E

Tech Center 1600 • Art Units: 1624 1626 1629

This examiner grants 68% of resolved cases

Analysis

USPTO examiner BRAUN, MADELINE E is assigned to Tech Center 1600 and Art Unit 1624. The record shows 154 resolved cases, a 68.2% allowance rate, a 25.4% interview lift, and a median of 1346 days to allowance. The figures support a positive but deliberate interview strategy.

Leading company matters include Hoffmann-La Roche Inc., University of Massachusetts, and Dana-Farber Cancer Institute Inc. Leading firms include FOLEY HOAG, LLP (General), THOMAS | HORSTEMEYER, LLP, and VIKSNINS HARRIS PADYS MALEN LLP. Practitioners should combine interview preparation with planning for the extended stated timeline.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

68.2%
Allow Rate
+8.2% vs TC avg
198
Total Applications
+25.4%
Interview Lift
1346
Avg Prosecution Days
Based on 154 resolved cases, 2023–2026

Rejection Statute Breakdown

1.2%
§101 Eligibility
17.0%
§102 Novelty
26.3%
§103 Obviousness
38.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18833591 COMPOSITIONS OF AUTOPHAGY MODULATING AGENTS AND USES THEREOF Non-Final OA Washington University
18861291 PENEM ANTIBACTERIALS AGAINST MYCOBACTERIAL PATHOGENS AND D,D- AND L,D TRANSPEPTIDASES Non-Final OA The Johns Hopkins University
18710037 METHOD OF TREATING CANCER ASSOCIATED WITH RAS MUTATION Non-Final OA The United States Government as Represented by The Department of Veterans Affairs
18126273 METHOD FOR TREATING DEMYELINATING CONDITIONS Final Rejection GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD.
18713496 SMALL MOLECULE INHIBITORS OF KRAS MUTATED PROTEINS Non-Final OA TAIHO PHARMACEUTICAL CO., LTD.
18678103 HETEROARYL SUBSTITUTED BETA-HYDROXYETHYLAMINES FOR USE IN TREATING HYPERGLYCAEMIA Non-Final OA ATROGI AB

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Madeline E Braun's allowance rate?

68.2% of resolved applications examined by Madeline E Braun were allowed (154 resolved cases), compared with 54.4% across Art Unit 1624 over the last five years.

Does an interview help with examiner Madeline E Braun?

This examiner's interview lift is +25.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Madeline E Braun take to allow a patent?

Applications allowed by Madeline E Braun took 1,346 days on average from filing to allowance.

Which art unit does examiner Madeline E Braun work in?

Madeline E Braun examines applications in Art Unit 1624 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month